Health care facilities that still use fixed endcap duodenoscopes, which are no longer marketed in the U.S., should complete their transition to newer models that have disposable components or are fully disposable, which emerging data suggest can lower infection risks, the Food and Drug Administration recommended this week. FDA has cleared seven duodenoscopes with disposable components that facilitate reprocessing or are fully disposable, and some manufacturers are offering replacement programs to upgrade to a model with a disposable component at no cost, the agency notes.

Related News Articles

Headline
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S.…
Headline
AHA today submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an…
Headline
Abbott has recalled certain lots of its Dragonfly OpStar imaging catheter because a marker band may separate from the catheter and remain in the patient after…
Headline
AHA today urged the Federal Trade Commission to scrutinize commercial health plans that steer patients to third-party specialty pharmacies in which they have a…
Headline
The Food and Drug Administration last week extended to 24 months the shelf life for certain lots of refrigerated bamlanivimab. The combination monoclonal…
Headline
Medtronic this week alerted health care providers to a defect in its Heartware Ventricular Assist Device System that may cause the internal pump to malfunction…